Lasers in gynaecology.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 25 09 2019
revised: 12 03 2020
accepted: 16 03 2020
pubmed: 7 6 2020
medline: 15 5 2021
entrez: 7 6 2020
Statut: ppublish

Résumé

The use of lasers to treat gynaecological and urogynaecological conditions including genitourinary syndrome of the menopause, stress urinary incontinence, vaginal prolapse and other conditions, has become increasingly popular over recent years. Following widespread concerns over the use of mesh for treating stress urinary incontinence and pelvic organ prolapse and potential adverse outcomes from the use of mesh, there has been heightened awareness and debate over the introduction and adoption of new technologies and interventions within the speciality. On July 30th 2018 the United States Food and Drug Administration (FDA) issued a warning against the use of energy based devices (EBDS) including laser to perform "vaginal rejuvenation" or vaginal cosmetic procedures. Numerous review articles and editorials have urged for greater evidence on the efficacy and safety of vaginal lasers This review outlines the evidence to date for the use of lasers in the treatment of gynaecological conditions.

Identifiants

pubmed: 32505055
pii: S0301-2115(20)30150-0
doi: 10.1016/j.ejogrb.2020.03.034
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

146-155

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Christian Phillips (C)

Consultant Gynaecologist and Urogynaecologist, Hampshire Hospitals, Hampshire, UK; Visiting Professor, University of Winchester, Hampshire, UK. Electronic address: phillipschaps@aol.com.

Tim Hillard (T)

Consultant Obstetrician and Gynaecologist, Poole Hospital NHS Foundation Trust, UK.

Stefano Salvatore (S)

Consultant Gynaecologist and Urogynaecologist, San Raffaele Hospital, Milan, Italy.

Phil Toozs-Hobson (P)

Consultant Gynaecologist and Urogynaecologist, Birmingham Women's Hospital, UK.

Linda Cardozo (L)

Consultant Gynaecologist and Urogynaecologist, Kings College Hospital, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH